Featured Journals

Why you should publish with US

Latest News & Analysis

Breast cancer treatment with Akt inhibitors

The PI3K/Akt signaling pathway is frequently hyperactivated in different types of breast cancer. In the past two decades, major efforts have been mad...

27 Feb 2023

Does language usage treat mental illness?

The language of patients offers a key opportunity to gain insight into their condition between appointments. A growing body of research indicates that...

27 Feb 2023

B12 treats injury induced by ischemia-reperfu...

Authors reported that oral high dose B12 decreases superoxide level and renal injury induced by ischemia/reperfusion in mice. Here, they discussed pot...

27 Feb 2023

Molecular signatures of pediatric liver cance...

The most dangerous form of pediatric liver cancer is aggressive hepatoblastoma, which can be characterized by chemo-resistance and multiple nodules or...

27 Feb 2023

Most Recent Articles

Gastric marginal zone B-cell lymphoma of MALT type – An updated histo- and molecular pathological summary

Author(s) : Francesca Spada, Thomas FE Bar...

Journal Name: J Clin Exp Gastroenterol

Publication Year: 2022

Potential biomarkers for MCL1 inhibitor sensitivity

Author(s) : Lei Duan, Carl G. Maki

Journal Name: Cell Signal

Publication Year: 2024

PDE4 inhibition and enhancement of human memory and cognition

Author(s) : Graeme B. Bolger

Journal Name: Cell Signal

Publication Year: 2025

See what people say about US